Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,907 followers.

RT @ohpenlab: While using COVID-19 drugs, they may have reactions with other drugs. This data-driven discovery study would provide some hyp…

RT @ohpenlab: While using COVID-19 drugs, they may have reactions with other drugs. This data-driven discovery study would provide some hyp…

RT @ohpenlab: While using COVID-19 drugs, they may have reactions with other drugs. This data-driven discovery study would provide some hyp…

RT @ohpenlab: While using COVID-19 drugs, they may have reactions with other drugs. This data-driven discovery study would provide some hyp…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.